Skip to main content
. Author manuscript; available in PMC: 2013 Sep 26.
Published in final edited form as: Pediatrics. 2010 Oct 18;126(5):e1261–e1318. doi: 10.1542/peds.2010-2972A

Disclosures. CoSTR Part 10: Worksheet Collaborator Disclosures.

Worksheet
Collaborator
Employment Research Grant Other Research Support Speakers's Bureau/Honoraria Ownership
Interest
Consultant/Advisory Board Other
Ian Adatia University of Alberta and Alberta Health Services; Professor Pediatrics, Director Pediatric Cardiac Critical Care Program and Pulmonary Hypertension Clinic None None None None None None
Richard P. Aickin Auckland District Health Board Government Funded Healthcare Provider (primary care through to tertiary hospital services) for Auckland population and for national tertiary services. Director of Child Health None None None None *New Zealand Health and Disability Commission: occasional expert reports provided with respect to alleged breaches of healthcare standards. 1–2 reports per year. Small personal payment received *Expert Witness: Occasional expert testimonyfor Coroner's Court and criminal (Child protection) cases Approx 1 × year. No personal payment—small payment to Auckland District Health Board for my time
John Berger Children's National Medical Center Nonprofit Children's hospital Medical Director, Cardiac Intensive Care and Pulmonary Hypertension 5 U 10 HD 049981—DL Wessel (PI) 12/1/09/–11/30/14 Sponsor: NIH/NICHD/NCMRR Pediatric Critical Care Research Network The major aims of the network are to reduce morbidity and mortality in pediatric critical illness and injury, and to provide a framework for the development of the scientific basis of pediatric critical care practice. I am responsible for conduct of network approved studies at CNMC. As a member of the network steering committee, I am responsible for contributing to design of studies, analyzing results and disseminating research findings. Grant money comes to institution. Role: Co-Investigator *Therapeutic Hypothermia after Pediatric Cardiac Arrest (THAPCA) Trials. PI:JT Berger 2009 Sponsor: of Michigan I am the site PI for the conduct of a randomized trial of therapeutic hypothermia in children who have had a cardiac arrest funded by NHLBI. Money comes to the institution. Role: Consortium Site PI *Tracking Outcomes and Practice in Pediatric Pulmonary Hypertension. PI: JT Berger. 2008 Sponsor: Association in Pediatric Pulmonary Hypertension I am the site PI responsible for contributing subject data to a registry of pediatric pulmonary hypertension patients and their therapy Role: Site PI None None None None None
Jeffrey M. Berman University of North Carolina:Faculty member UNC School of Medicine—Professor of Anesthesiology None None None None None None
Desmond Bohn The Hospital for Sick Children, Toronto—Chief, Department of Critical Care Medicine None None None None None None
Kate L. Brown Great Ormond Street Hospital for Children NHS Trust Hospital consultant in paediatric intensive care Consultant paediatric cardiac intensive care None None None None None None
Mark G. Coulthard Queensland Health: State Health Employer Organisation—Paediatric Intensive Care Specialist None None None None None None
Douglas S. Diekema Children's University Medical Group: Delivery of medical care in Children's Hospital of Seattle and the University of Washington—Professor of Pediatrics, Attending Physician, Emergency Department None None None None None None
Aaron Donoghue University of Pennsylvania—Assistant Professor None None None None None None
Jonathan Duff Alberta Health Services: Pediatric Intensivist None None None None None None
Jonathan R. Egan The Children's hospital at Westmead, Sydney—Pediatric Intensivist None None None None None None
Christoph B. Eich University Medical Centre of Göttingen, Germany: Attending Anesthesiologist, Intensivist and Emergency Physician None None None None None None
Diana G. Fendya Children's National Medical Center, EMSC National Resource Center; Trauma/Acute Care Nursing Specialist None None None None None None
Ericka L. Fink Children's Hospital of Pittsburgh of UPMC—Assistant Professor P.I., K23 from NINDS Duration of Hypothermia for Neuroprotection after Pediatric Cardiac Arrest Institution P.I., Laerdal Foundation grant $21, 365 Same topic Institution *Children's Hospital of Pittsburgh of UPMC Clinical and Translational Science Institute $6500 Same topic Institution None None None None None
Loh Tsee Foong KK Women's and Children's Hospital None None None None None None
Eugene B. Freid Nemours Children's Clinics Health Care Organization Staff Anesthesiologist and Intensivist University of Florida Jacksonville Health Care Organization Pediatric Intensivist None None *University of North Carolina—Speaker at Anesthesiology Refresher Course. 1000–1500/year honorarium sent to institution None None None
Susan Fuchs Children's Memorial Hospital-Assoc Director, Div Pediatric Emergency Medicine None None None None None *Currently on the American Academy of Pediatrics Advanced Pediatric Life Support Steering Committee and Currently Co-chairperson of the AAP Pediatric Education for Prehospital Professional (PEPP) steering committee
Anne-Marie Guerguerian The Hospital for Sick Children; Staff Physician None None None None None None
Bradford D. Harris UNC at Chapel Hill; Assist Prof 5 P01 AT002620–02 (Peden) 09/30/04–06/30/09 5% NIH/NCCAM $1, 660, 813 Annual Direct Translational Research Center for CAM Therapy of Asthma The objective of this research is to identify antioxidant complementary and alternative medicine therapies for application in asthma. 5 RO1 ES012706–02 (Peden) 09/01/04–07/31/09 5% NIH/NIEHS $ 209, 314 O3 and LPS-Induced Airway Inflammation in Humans in vivo The objective is to test three hypotheses to define the ways that O3 and LPS interact to exacerbate airway disease. 5 R01 HL080337–02 (Peden) 05/06/05–04/30/09 5% NIH NHLBI/NIAID $350, 000 Airway Biology of Acute Asthma: Translational Studies The major goal is to determine if asthma exacerbation and allergen challenge models allow for examination of innate/acquired immune interactions. R82952201 Cooperative Agreement (Bromberg) 11/01/01–10/31/06 5% U.S. Environmental Protection Agency $1, 583, 867 Health Effects of Exposure to Air Pollutants in Humans The major goal of this cooperative agreement is to examine the health effects of inhalation of environmental ambient air pollutants on human subjects None *Assoc Clinical Research Professor on peds pharm None None None
George M. Hoffman Medical College of Wisconsin medica school Professor, Anesthesiology and Pediatrics [View] Children's Hospital of Wisconsin hospital Medical Director, Pediatric Anesthesiology None None *Somanetics, Inc biomedical device manufacturer 1653 East Maple Road Troy, MI 48083-4208 i have informally served in consultant/advisory capacity and have received honoraria for speaking None *Edwards Life Sciences, Inc biomedical device manufacturer One Edwards Way Irvine, CA 92614 i have served informally in consultant/advisory capacity *Masimo, Inc biomedical device manufacturer 2852 Kelvin Ave. Irvine, CA, 92614 i have served informally in consultant/advisory capacity None
James S. Hutchison SickKIds Hospital Director Neurocritical Care None None None None None None
Sharon B. Kinney University of Melbourne and Royal Children's Hospital Melbourne—Lecturer and MET Coordinator None None None None None None
Sasa Kurosawa Shizuoka Children's Hospital Depertoment of Pediatric Emergency & General Pediatrics Doctor National Center for Child Health & Development Department of Health Policy, Research Institution researcher None None None None None None
Jesús López-Herce Hospital General Universitario Gregorio Marañón—Pediatric Assistant None None None None None None
Sharon E. Mace Clerveland Clinic—Physician employed fulltime by the hospital; Attending staff physician None None *Baxter Healthcare Pharmaceutical Speaker Bureau None *Baxter Healthcare Pharmaceutical Consultant, Advisory Board None
Ian Maconochie Imperial Academic Health Sciences Centre, London: I run the pediatric emergency medicine department at St Mary's Hospital in Paddington, London—Lead Consultant in Pediatric Emergency medicine None *Postal for survey of UK departments about use of pain relief from Therakind, a company looking to obtain license for use of commonly used drugs from the medical regulatory authority in UK. Estimated payment was about 150 pounds sterling None None *I am a deputy editor for The Emergency Medicine Journal, a commissioning editor for the Archives of Diseases of Childhood and sit on the editorial advisory panel for the British Medical Journal. I am editorial board member for Current Pediatric Reviews and Pediatric Emergency Medical Journal. The latter 2 I do not receive payment. I act as a consultant advisory to TSG associates in relation to major disaster management systems. I have advised Therakind on the licensing of drugs in the pediatric population., ie approaching the medical regulatory authority to obtain a license on the use of a commonly used drug in the treatment of fitting children in UK *I have acted as an expert witness in cases relating to the management of children who may have had non accidental injury.
Duncan Macrae The Royal Brompton and Harefield NHS Foundation Trust—Director of Children's Services None None None None None None
Mioara D. Manole Univ of Pittsburgh: Ped Emerg. Medicine attending physician; assist Prof Ped NIH K08HD58798-funds go to Univ Children's Hosp of Pitts RAC grant-funds to Univer. None None None None None
Bradley S. Marino Cincinnati Children's Hospital Medical Center Associate Professor of Pediatrics None None None None None None
Felipe Martinez Universidad de Valparaíso—Professor None None None None None None
Reylon A. Meeks Blank Children's Hospital, Pleasant Hill Fire Dept., N Clinical Specialist None None None None None None
Alfredo Misraji Unidad Coronaria Movil None None None None None None
Marilyn Morris Columbia Univ; assist Prof Ped None None None None None *Expert witness $900 for 3 hour case for defense of child that received ECPR
Akira Nishisaki Children's Hosp of Philadelphia, non profit tertiary Children's hospital; attending MD CCMedicine None None None None None None
Masahiko Nitta Osaka Medical College—Assistant Professor None None None None None None
Gabrielle Nuthall Auckland District Health Board: Pediatric Intensive Care Specialist None None None None None None
Sergio Pesutic Pérez Centro de Formación en Apoyo Vital Director None None None None None None
Lester T. Proctor University of Wisconsin-Madison College of Medicine and Public Health—Professor None None None None None None
Faiqa A. Qureshi Children's Specialty Group—Physician None None None None None None
Sergio Rendich Hospital Naval Almirante Nef—Pediatrician; Hospital Gustavo Fricke; Pediatrician—Intensive Care Unit; Universidad de Valparaíso Professor, Pediatrics Clínica Las Condes Critical Patient Unit Centro de Formación en Apoyo Vital; Instructor, NRP None None None None None None
Ricardo A. Samson The University of Arizona: Faculty member within the Department of Pediatrics Chief of the Cardiology Section Provide clinical care, teaching and research related to the field of Pediatric Cardiology—Professor of Pediatrics None None None None None None
Kennith Sartorelli University of Vermont Associate Professor of Surgery None None None None None None
Stephen M. Schexnayder University of Arkansas for Medical Sciences–College of Medicine: Physician - Clinician Educator–Professor and Division Chief: AHA Consultant *Pharmacokinetics of pantoperazole in pediatrics patients (Pediatric Pharmacology Research Unit) Pharmacokinetics of esomeprazole in pediatric patients (Astra Zeneca) None *Contemporary Forums (Nursing conference) Pediatric Clinics of North America (guest editor) None None *Expert witness in various medicolegal cases involving pediatric critical care and emergency medicine
William Scott UT Southwestern Medical Center—Professor None None None None None None
Vijay Srinivasan Children's Hospital of Philadelphia—Attending Physician, Pediatric Intensive Care Unit *A Reproducible Method for Blood Glucose Control in Critically Ill Children (RC1 sub contract with Inter Mountain Medical Center, PI: Alan Morris), site PI: Vijay Srinivasan—submitted for NIH Challenge Grants July 2009, approval pending *PI: A Novel Application of Impedance Threshold Device technologies to optimize Fluid Removal during Hemodialysis in Children (unfunded research at CHOP—IRB Research Protocol No: 2007–12-5712)—have received impedance threshold devices for this study from Advanced Circulatory Systems, Inc, EdenPrairieMN None None None None
Robert M. Sutton The Children's Hospital of Philadelphia Critical Care Attending *Unrestricted research grant support from the Laerdal Foundation for Acute Care Medicine None None None None None
Mark Terry Johnson County Med-Act: County government ambulance service—Deputy Chief Operations None None None None None None
Shane Tibby Guy's and St Thomas' NHS Foundation Trust, London National Health Service Hospital trust in United Kingdom Consultant in Pediatric Intensive Care None None None None None None
Alexis Topjian The Children's Hospital of Philadelphia—attending physician *site PI for the Therapeutic hypothermia after cardiac arrest study. NIH funded study. Money goes to the institution None None None None None
Elise W. van der Jagt University of Rochester: Academic Institution including Medical School/Center—Professor of Pediatrics and Critical Care Project Title: Therapeutic Hypothermia After Pediatric Cardiac Arrest (THAPCA) Trials PI: Frank W. Moler, M.D. (University of Michigan) Proposed project period: 7/1/2009–6/30/2014 We are part of this multi-institutional grant but after the grant was funded, the initial institutions that would be involved were the higher volume/larger Children's hospitals. At this time we are not receiving any funding from this grant. *PI andCo-Investigator/Site None None None None None
David Wessel Children's National Medical Center Senior Vice President None None None None IKARIA Holdings Inc Pharmaceutical Consultant None

This table represents the relationships of worksheet collaborators that may be perceivedas actual or reasonably perceived conflictsofinterest asreported on the Disclosure Questionnaire, which all worksheet collaborators are required to complete and submit. A relationship is considered to be “significant” if (a) the person receives $10 000 or more during any 12-month period, or 5% or more of the person's gross income; or (b) the person owns 5% or more of the voting stock or share of the entity, or owns $10 000 or more of the fair market value of the entity. A relationship is considered to be “modest” if it is less than “significant” under the preceding definition.

*

Modest.

Significant.